Ingresar
Pharmaceutical Inventions. Procedures by ANVISA related to its prior consent decisions
By Pedro Moreira, partner Dannemann Siemsen
On April 12, 2017, the Brazilian Patent and Trademark Office (INPI) and ANVISA formally signed Joint Ordinance no. 01 on examination of pharmaceutical patent applications, which regulates the procedures for applying said Article 229-C of the Brazilian IP Law, aiming at finally solving the conflict and polemic on double examination that has been carried out so far by them. For further details, please see our Newsletter of April 12, 2017.
INPI published their ruling on this matter on June 27, 2017, namely Normative Instruction no. 01, providing guidelines on administrative procedures at the PTO's sphere, as reported in our Circular no. 07 of June 2017.
ANVISA's RDC 168/2017 contains directives on administrative procedures in the Agency's sphere, which were formerly foreseen in its Resolution no. 45 of June 23, 2008 (RDC 45/2008) and Resolution no. 21 of April 10, 2013 (RDC 21/2013). This new Resolution basically brings no alteration and merely ratifies the above-mentioned Joint Ordinance no. 01 and Normative Instruction no. 01.
We now have to await further developments with a view to have confirmation as to how the above new rules will be implemented in practice by ANVISA and INPI.
The above RDC 168/2017 is in force as of today, August 10, 2017, and revokes former RDC 45/2008 and RDC 21/2013.
The original version of RDC 168/2017 can be downloaded here. If you need an English version thereof or any additional information about any specific case, please let us know.
(1) "Article 229-C - The grant of patents for pharmaceutical products and processes will depend on prior consent from the National Agency for Sanitary Surveillance [ANVISA]."
Dannemann Siemsen
Recognised as leaders in Intellectual Property in Latin America, we are a team of experts who has been dedicated to defending industrial and intellectual property since 1900. We operate throughout the world, encompassing first-rate civil and criminal advocacy, covering diverse areas of Law and all segments of industry. We are partners of large national and international companies.
Today we have offices in three Brazilian state capitals and we have gathered a team of practitioners that lead in knowledge of intellectual property, litigation, contracts and other areas of Law.
This allows us to advise our clients in the main legal proceedings, making us a strategic partner in the pursuit of innovation and knowledge.
We have more than 280 lawyers and an extensive team of Industrial Property Agents – an experienced and specialised technical team that is kept up-to-date with the transformations and demands of the market.
We are the support for innovation and knowledge.
We live in a dynamic world, where knowledge is decisive for any company to stand out in the market. We believe in the value of human capital and in creativity as a source of innovation.
With more than a century of experience and a wide range of services, we are proud to be the foundation for our clients to seek innovative and disruptive paths.
